StonvexLoading…
StonvexStonvexStonvexCore line items from AWK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.20B | $5.12B | $3.85B | $2.41B |
Operating Income | $391.00M | $1.88B | $1.47B | $860.00M |
Net Income | $196.00M | $1.11B | $873.00M | $289.00M |
EPS (Diluted) | $1.00 | $5.69 | $4.47 | $2.53 |
Total Assets | $35.26B | $35.44B | $34.75B | $33.91B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $137.00M | $98.00M | $166.00M | $94.00M |
Free Cash Flow OCF − CapEx | $-354.00M | $-1.07B | $-682.00M | $-649.00M |
Shares Outstanding | 195.00M | 195.00M | 195.00M | 195.00M |